ctrl K

Watchlist Price Alert

Drugs Made In America Acq... (DMAAR)

NASDAQ: DMAAR · Real-Time Price · USD

0.13

-0.02 (-13.33%)

At close: May 23, 2025, 2:37 PM

0.13

0.00%

After-hours: May 23, 2025, 02:37 PM EDT

Drugs Made In America Acquisition Rights Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024
Period Ending	Dec 31, 2024
Revenue	n/a
Cost of Revenue	n/a
Gross Profit	n/a
Operating Income	-479.73
Interest Income	n/a
Pretax Income	-479.73
Net Income	-479.73
Selling & General & Admin	479.73
Research & Development	n/a
Other Expenses	n/a
Operating Expenses	479.73
Interest Expense	n/a
Selling & Marketing Expenses	n/a
Cost & Expenses	479.73
Income Tax Expense	n/a
Shares Outstanding (Basic)	8.57K
Shares Outstanding (Diluted)	8.57K
EPS (Basic)	-0.06
EPS (Diluted)	-0.06
EBITDA	n/a
EBIT	-479.73
Depreciation & Amortization	479.73